Tethis has created a nanoparticle deposition facility used for the production of microscopy slides employed in the detection of circulating tumor cells in the blood (ctc).
This instrument is essential for preparing high-quality slides used in the analysis of liquid biopsy samples, such as blood, to diagnose and monitor diseases, particularly cancer.
The client is an Italian SME specializing in liquid biopsy, a diagnostic technique that promises to revolutionize the management of cancer, detecting it earlier and guiding treatment more effectively.
To ensure accurate results, Tethis commissioned Kaira Engineering to develop the Control Unit to automate the process of nanoparticle deposition on installed substrates. The system can be used with the same nanoparticle deposition technology to process a variety of substrates for other applications.
The formation of nanoparticles in the plant occurs through the generation of high vacuum.
The nanoparticles thus generated, using appropriate mechanical conduits, are directed toward the material to be subjected to deposition.
A rotation unit inside the deposition chamber allows multiple products to be exposed at the same time.
Kaira Engineering, the perfect partner for all MedTech companies that need professional consultancy services to keep up to date with the latest trends and requirements of the medical industry.